We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA to Make List of Possible Avandia Warnings, OSE Director Says
FDA to Make List of Possible Avandia Warnings, OSE Director Says
August 3, 2007
The FDA will formulate a list of warnings that should be added to Avandia’s labeling based on data and advisory committee recommendations, Office of Surveillance and Epidemiology Director (OSE) Gerald Dal Pan said.